Medications starting with

Poland
  • ELOCOM

    It is used to relieve itching and inflammatory symptoms in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Salud, S.L.

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Salud, S.L.

  • The medicine is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Salud, S.L.

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • It is used to relieve itching and inflammatory symptoms in skin diseases that respond to corticosteroid treatment, such as atopic dermatitis and psoriasis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • The medicine is used to relieve inflammation and itching in skin diseases that respond to corticosteroids, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as atopic dermatitis and psoriasis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: ORGANON BIOSCIENCES S.R.L.

  • It is used to relieve itching and inflammatory symptoms in skin diseases that respond to corticosteroid treatment, such as atopic dermatitis and psoriasis.

    Dosage form: cream

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • The medicine is used to relieve itching and inflammatory symptoms in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: cream

    ATC code: D07AC13

    Manufacturer: Organon Salud, S.L.

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Belgium

  • It is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Belgium

  • The medicine is used to relieve inflammation and itching of the hairy scalp in conditions such as psoriasis and atopic dermatitis.

    Dosage form: solution, topical

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • The medicine is used to relieve inflammatory symptoms and itching of the hairy scalp in diseases such as psoriasis and atopic dermatitis.

    Dosage form: solution, topical

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Healthcare GmbH

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • The medicine is used to relieve inflammatory symptoms and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • It is used to relieve inflammation and itching in skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Salud, S.L.

  • It is used to relieve inflammation and itching on the hairy scalp in conditions such as psoriasis and atopic dermatitis.

    Dosage form: solution, topical

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: N.V. Organon

  • It is used to relieve inflammatory symptoms and itching of the hairy scalp in conditions such as psoriasis and atopic dermatitis.

    Dosage form: solution, topical

    Active substance Dosage
    mometasone furoate 1 mg/g

    ATC code: D07AC13

    Manufacturer: Organon Healthcare GmbH

  • The medicine is used as a supportive treatment in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin caused by the herpes simplex virus.

    Dosage form: tablets

    Active substance Dosage
    inosine pranobex 500 mg

    ATC code: J05AX05

    Manufacturer: Polfarmex S.A.

  • It is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).

    Dosage form: syrup

    Active substance Dosage
    inosine pranobex 500 mg/5 ml

    ATC code: J05AX05

    Manufacturer: Polfarmex S.A.

  • It is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).

    Dosage form: tablets

    Active substance Dosage
    inosine pranobex 1000 mg

    ATC code: J05AX05

    Manufacturer: Polfarmex S.A.

  • The medicine is used to relieve itching and inflammatory symptoms of skin diseases that respond to corticosteroid treatment, such as psoriasis and atopic dermatitis.

    Dosage form: cream

    Active substance Dosage
    mometasone furoate 0.1 g

    ATC code: D07AC13

    Manufacturer: EMO-FARM Sp. z o.o.

  • It is used for short-term, topical treatment of skin diseases that cause itching and respond to glucocorticoids, such as psoriasis and atopic dermatitis.

    Dosage form: ointment

    Active substance Dosage
    mometasone furoate 1 mg

    ATC code: D07AC13

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • It is used to relieve inflammatory symptoms and itching on the hairy scalp in diseases such as psoriasis and atopic dermatitis.

    Dosage form: solution, topical

    Active substance Dosage
    mometasone furoate 1 mg/ml

    ATC code: D07AC13

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus infection who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus infection who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC code: B02BX05

    Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with a low platelet count caused by hepatitis C virus infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

  • The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after previous treatment with other methods) and in adults with hepatitis C virus infection who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH

  • This medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC code: B02BX05

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

  • The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

  • The medicine is used to increase the number of blood platelets. It is used to treat immune thrombocytopenia in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with a low platelet count due to hepatitis C virus infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 12.5 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have experienced difficulties due to adverse effects during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of platelets. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have a low platelet count that makes antiviral treatment difficult.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have experienced difficulties due to adverse effects during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 12.5 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (when other medicines have not worked) and in adults with hepatitis C virus infection who have experienced difficulties due to adverse effects during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • This medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count caused by hepatitis C virus infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 12.5 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • This medicine is used to increase the number of blood platelets. It is prescribed for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count due to hepatitis C virus infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (who have not responded to other medicines) and in adults with hepatitis C virus who have a low platelet count.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (in individuals over 1 year of age for whom other medicines have not worked) and in adults with a low platelet count due to hepatitis C virus infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC code: B02BX05

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have difficulties due to a low platelet count during interferon treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC code: B02BX05

    Manufacturer: Centrafarm Services B.V.